RS, F., TO, C., E, M., CJ, S., MDM, G. R., JW, D., . . . S, F. (2026). Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. Nature medicine, 32(5), 1936. https://doi.org/10.1038/s41591-026-04415-5
Chicago Style (17th ed.) CitationRS, Finkel, et al. "Author Correction: High-dose Nusinersen for Spinal Muscular Atrophy: A Phase 3 Randomized Trial." Nature Medicine 32, no. 5 (2026): 1936. https://doi.org/10.1038/s41591-026-04415-5.
MLA (9th ed.) CitationRS, Finkel, et al. "Author Correction: High-dose Nusinersen for Spinal Muscular Atrophy: A Phase 3 Randomized Trial." Nature Medicine, vol. 32, no. 5, 2026, p. 1936, https://doi.org/10.1038/s41591-026-04415-5.
Warning: These citations may not always be 100% accurate.